Cum enim release de "14 quinque - anno consilio" pro progressionem de pharmaceutical industria, quae elevatur in pharmaceutical industria est scriptor partes, et nationalibus securitati, a series et continuously implemented, in series sunt continuously et continuatae sunt, in seriem sunt continue implemented. Related ad Innovative medicamento R & D Efficens, Market Access, Patent Tutela, et Morbi cursus sapien approbatione facti calidum topics ad National Populi Congresso et Chinese Populi Political Consultivo in Development et EVOLVS de "et" ad "custodientes viam" et "ducens viam." Et stabilis firmat ejus innovation et R & D elit, in industria expanded significantly et facti a key exactoris ex oeconomica incrementum et technicae incrementum.
Ut adhuc coegi innovation et cooperante in agro BIOTECHNOLOGY in Sina, in April 7th, KPMG Sina Hosted in "2 BIOTECHNOLOGY Top L Award Awards CAEMENTIY" eodem in Beijing, Shanghai et Shenzhen. Hoc eventus congregentur numerosis peritos et scholarium ex industria ad dimicandum in disputationibus in Cutting - Edge Topics et Future Spes in BIOTECHNOLOGY.
Jiangsu Home Biopharma Co., Ltd (referred to as "Hebnĭgene") est late agnita et laudavit per industria pro sua provectus technology et innovative capabilities in agro cellula Lorem medicamento contractus progressionem et vestibulum (CDMo). Post a comprehensive iudicium, comprehendo Document Review, Electio et Field Research conducted by KPMG Sina et peritus
Iudicare committee, Hebni scriptor altiore vires et innovation res gestae suscepit altum laudem ex peritos iudices, ultimately promerendae locus in KPMG Sinis scriptor 2nd "Biotechnology Innovation summo L conatibus" album.
Hoc lectio processus involved aestimandis conatibus ex variis dimensionibus, comprehendo foro productum aemulationes, innovative negotium exempla, addressing industria dolor puncta, et financial salutem. In innovation intenditur ad eligere promittens promittentes biotechnology conatibus qui potest ad altum - qualis et sanus progressionem Sinis scriptor Biotechnology innovation industria et creare in ECOSYNTIFIED ADVENTIVE STARing PROMODIUM in HIGRESSUS, etiam progressionem ad industria est altum - qualis et progressionem ad industria est in High - qualis et sanus progressionem.
Post tempus: MMXXIII - V - XXIX 00:00:00
